Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016 [0.03%]
早期乳腺癌治疗及预后因素-圣安东尼奥乳腺癌研讨会2016年会后综述
Christoph Suppan,Marija Balic
Christoph Suppan
Developments in early breast cancer presented at the 2016 San Antonio Breast Cancer Symposium included important studies on extending adjuvant endocrine therapy with aromatase inhibitors, the role of bisphosphonates, and evidence for molecu...
Clemens Feistritzer,Birgit Mosheimer
Clemens Feistritzer
During the annual meeting of the American Society of Hematology (ASH) in San Diego/California, novel developments in the field of hemostaseology were presented. Alternative treatment strategies besides factor replacement were discussed for ...
News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation [0.03%]
2016ASH国际年会淀粉样变性病研究进展：一个迅速发展的领域
Hermine Agis
Hermine Agis
Amyloidosis is a rare but life-threatening protein misfolding disease. The early diagnosis and enrollment of patients into multicentre trials is of great importance, as is the need for intensive collaboration between multiple medical depart...
M Dediu,A Gerger,N Zojer et al.
M Dediu et al.
Results of several clinically relevant studies were presented at the 2016 Annual Meeting of the European Society of Medical Oncology (ESMO). This article summerizes the personal highlights of three medical oncologists in their respective ar...
Leonhard Müllauer
Leonhard Müllauer
Autopsy, histology and cytology have been and histology and cytology still are the main diagnostic tools in surgical pathology. During the last two decades molecular biology gradually has extended the diagnostic armamentarium. In tumor path...
Robert Pirker
Robert Pirker
Several milestones in the systemic treatment of lung cancer have been reached. Combination chemotherapy of small cell lung cancer was the first of these milestones. The establishment of palliative chemotherapy in patients with advanced non-...
Christine Marosi,Matthias Preusser
Christine Marosi
For neuro-oncologists, much was accomplished in the last decade, including the establishment of the first standard of care (SOC) in this field of oncology. New treatment options boosted research in the whole field of neuro-oncology, as well...
Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo [0.03%]
慢性淋巴细胞白血病的里程碑：令人兴奋的进步十年——纪念memo研究十周年
Alexander Egle
Alexander Egle
The past 10 years have been an exciting ride for Chronic Lymphocytic Leukemia (CLL) aficionados. An overview of changes in management paradigms in CLL, ranging from insights into biology, via chemotherapy and chemoimmunotherapy to maintenan...
Extravasation emergencies: state-of-the-art management and progress in clinical research [0.03%]
extravasation急症的临床研究新进展与治疗策略展望
Ursula Pluschnig,Werner Haslik,Rupert Bartsch et al.
Ursula Pluschnig et al.
In cancer treatment, extravasation is defined as an inadvertent instillation or leakage of cytotoxic drugs into the perivascular space during infusion. As a dreaded complication of chemotherapy, extravasation has gained increasing attention...
Rupert Bartsch,Elisabeth Bergen
Rupert Bartsch
At the 2016 ASCO Annual Meeting, several pertinent studies in the field of breast cancer were presented. MA17.R was the first randomized phase III trial to evaluate the prolongation of adjuvant aromatase-inhibitor (AI) therapy from 5 to 10 ...